Display options
Share it on

Nucl Med Mol Imaging. 2014 Dec;48(4):278-86. doi: 10.1007/s13139-014-0283-3. Epub 2014 Jun 11.

Autoclustering of Non-small Cell Lung Carcinoma Subtypes on (18)F-FDG PET Using Texture Analysis: A Preliminary Result.

Nuclear medicine and molecular imaging

Seunggyun Ha, Hongyoon Choi, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, Euishin Edmund Kim, Dong Soo Lee

Affiliations

  1. Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea ; Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Korea.
  2. Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea ; Cancer Research Institute, Seoul National University, Seoul, Korea ; Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu Seoul, 110-744 Korea.
  3. Department of Nuclear Medicine, Seoul National University Hospital, Seoul, Korea ; Cancer Research Institute, Seoul National University, Seoul, Korea.
  4. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Korea ; Department of Radiological Science, University of California at Irvine, Irvine, CA USA.

PMID: 26396632 PMCID: PMC4571663 DOI: 10.1007/s13139-014-0283-3

Abstract

PURPOSE: Texture analysis on (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) scan is a relatively new imaging analysis tool to evaluate metabolic heterogeneity. We analyzed the difference in textural characteristics between non-small cell lung carcinoma (NSCLC) subtypes, namely adenocarcinoma (ADC) and squamous cell carcinoma (SqCC).

METHODS: Diagnostic (18)F-FDG PET/computed tomography (CT) scans of 30y patients (median age, 67; range, 42-88) with NSCLC (17 ADC and 13 SqCC) were retrospectively analyzed. Regions of interest were manually determined on selected transverse image containing the highest SUV value in tumors. Texture parameters were extracted by histogram-based algorithms, absolute gradient-based algorithms, run-length matrix-based algorithms, co-occurrence matrix-based algorithms, and autoregressive model-based algorithms. Twenty-four out of hundreds of texture features were selected by three algorithms: Fisher coefficient, minimization of both classification error probability and average correlation, and mutual information. Automated clustering of tumors was based on the most discriminating feature calculated by linear discriminant analysis (LDA). Each tumor subtype was determined by histopathologic examination after biopsy and surgery.

RESULTS: Fifteen texture features had significant different values between ADC and SqCC. LDA with 24 automate-selected texture features accurately clustered between ADC and SqCC with 0.90 linear separability. There was no high correlation between SUVmax and texture parameters (|r| ≤ 0.62).

CONCLUSION: Each subtype of NSCLC tumor has different metabolic heterogeneity. The results of this study support the potential of textural parameters on FDG PET as an imaging biomarker.

Keywords: Carcinoma; Cluster analysis; F-18 Fluorodeoxyglucose; Non-small cell lung; Positron emission tomography; Texture analysis

References

  1. Nucl Med Mol Imaging. 2013 Dec;47(4):232-41 - PubMed
  2. J Digit Imaging. 2013 Aug;26(4):797-802 - PubMed
  3. Ann Nucl Med. 2013 Nov;27(9):867-9 - PubMed
  4. N Engl J Med. 2010 Jun 24;362(25):2380-8 - PubMed
  5. J Nucl Med. 2013 Jan;54(1):19-26 - PubMed
  6. Magn Reson Imaging. 2004 Jan;22(1):81-91 - PubMed
  7. Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1191-202 - PubMed
  8. Acad Radiol. 2010 Feb;17(2):135-41 - PubMed
  9. Lung Cancer. 2013 Mar;79(3):242-7 - PubMed
  10. J Nucl Med. 1994 Oct;35(10 ):1653-5 - PubMed
  11. JSLS. 2004 Jul-Sep;8(3):213-6 - PubMed
  12. J Nucl Med. 2003 Sep;44(9):1426-31 - PubMed
  13. Insights Imaging. 2012 Dec;3(6):573-89 - PubMed
  14. Acta Oncol. 2010 Oct;49(7):1012-6 - PubMed
  15. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):133-40 - PubMed
  16. Nucl Med Commun. 2009 Nov;30(11):831-7 - PubMed
  17. Nucl Med Mol Imaging. 2013 Mar;47(1):36-43 - PubMed
  18. Clin Radiol. 2004 Dec;59(12 ):1061-9 - PubMed
  19. Respirology. 2013 May;18(4):734-5 - PubMed
  20. Nucl Med Mol Imaging. 2014 Mar;48(1):1-15 - PubMed
  21. Yale J Biol Med. 2010 Jun;83(2):53-65 - PubMed
  22. Eur J Nucl Med Mol Imaging. 2013 Dec;40(12 ):1836-42 - PubMed
  23. Cancer Res Treat. 2012 Mar;44(1):11-24 - PubMed
  24. J Thorac Oncol. 2008 Sep;3(9):971-8 - PubMed
  25. Eur J Radiol. 2013 Oct;82(10 ):e537-43 - PubMed

Publication Types